Cardio Diagnostics: Paul Burton
Paul Burton has been appointed to the board of directors of Cardio Diagnostics as an independent director. He will chair the nominating and corporate governance committee and be a member of the audit committee. Burton is a managing partner at 2Flo Ventures and CEO of Akan Biosciences. Previously, he was CEO of several venture-based therapeutics companies. He holds JD and MBA degrees from the University of Illinois Urbana-Champaign.